三星医疗9月9日获融资买入2704.30万元，融资余额4.64亿元

Group 1 - On September 9, Samsung Medical experienced a decline of 1.41% with a trading volume of 379 million yuan, and the net financing buy was -13.11 million yuan [1] - As of September 9, the total margin balance for Samsung Medical was 467 million yuan, with a financing balance of 464 million yuan, accounting for 1.43% of the circulating market value [1] - The company’s main business revenue composition includes 79.70% from the power sector, 19.15% from medical services, and 1.15% from other businesses [1] Group 2 - As of June 30, the number of shareholders for Samsung Medical increased to 29,000, a rise of 76.91%, while the average circulating shares per person decreased by 43.15% to 48,732 shares [2] - For the first half of 2025, Samsung Medical reported a revenue of 7.972 billion yuan, a year-on-year increase of 13.93%, and a net profit attributable to shareholders of 1.230 billion yuan, up 6.93% year-on-year [2] - Since its A-share listing, Samsung Medical has distributed a total of 5.728 billion yuan in dividends, with 2.650 billion yuan distributed in the last three years [3]